On October 27, 2023, the company announced an increase in its equity buyback plan. The company increased its authorization by CNY 100 million, thereby bringing its total authorization to CNY 300 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.3 CNY | +3.52% | +2.08% | -15.95% |
Apr. 29 | Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold | MT |
Apr. 26 | Yunnan Botanee Bio-Technology Group Co.LTD Proposes Final Dividend for 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.95% | 3.21B | |
+11.81% | 18.86B | |
0.00% | 17.37B | |
-0.75% | 10.65B | |
-7.25% | 10.26B | |
+7.52% | 6.72B | |
+10.34% | 5.94B | |
-0.06% | 4.55B | |
-18.21% | 3.83B | |
-3.97% | 3.48B |
- Stock Market
- Equities
- 300957 Stock
- News Yunnan Botanee Bio-Technology Group Co.LTD
- Yunnan Botanee Bio-Technology Group Co.LTD announces an Increase in Equity Buyback.